Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Garner

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Carcinogenesis|May 1, 1985
6-Nitrochrysene is a potent tumorigen in newborn miceW F Busby, R C Garner, F L Chow, et al.
International Journal of Cancer|February 6, 1999
Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low doseR J Mauthe, K H Dingley, S H Leveson, et al.
Investigational New Drugs|March 10, 2007
Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometryJ H Beumer, R C Garner, M B Cohen, et al.
Chemical Research in Toxicology|April 17, 1998
Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humansR J Turesky, R C Garner, D H Welti, et al.
Cancer Letters|September 30, 1999
Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low dosesK W Turteltaub, K H Dingley, K D Curtis, et al.
Carcinogenesis|February 14, 2003
Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancerJ H Barrett, G Smith, R Waxman, et al.
Clinical Pharmacology and Therapeutics|October 29, 2010
Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivoJ Chen, R C Garner, L S Lee, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitorR C Garner, I Goris, A A E Laenen, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 17, 2004
The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposureB C Cupid, T J Lightfoot, D Russell, et al.
Cancer Letters|September 30, 1999
Comparative biotransformation studies of MeIQx and PhIP in animal models and humansR C Garner, T J Lightfoot, B C Cupid, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Carcinogenesis|May 1, 1985
6-Nitrochrysene is a potent tumorigen in newborn miceW F Busby, R C Garner, F L Chow, et al.
International Journal of Cancer|February 6, 1999
Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low doseR J Mauthe, K H Dingley, S H Leveson, et al.
Investigational New Drugs|March 10, 2007
Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometryJ H Beumer, R C Garner, M B Cohen, et al.
Chemical Research in Toxicology|April 17, 1998
Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humansR J Turesky, R C Garner, D H Welti, et al.
Cancer Letters|September 30, 1999
Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low dosesK W Turteltaub, K H Dingley, K D Curtis, et al.
Carcinogenesis|February 14, 2003
Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancerJ H Barrett, G Smith, R Waxman, et al.
Clinical Pharmacology and Therapeutics|October 29, 2010
Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivoJ Chen, R C Garner, L S Lee, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitorR C Garner, I Goris, A A E Laenen, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 17, 2004
The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposureB C Cupid, T J Lightfoot, D Russell, et al.
Cancer Letters|September 30, 1999
Comparative biotransformation studies of MeIQx and PhIP in animal models and humansR C Garner, T J Lightfoot, B C Cupid, et al.
Pageof 10